• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 63 of 100
Daily Antiretroviral Pill Found To Protect Healthy From AIDS Transmission
Health5 Major Trends That Shaped Biopharma’s 2016
By Sy MukherjeeDecember 26, 2016
Biogen to Fire Workers, Restructure R&D After Difficult Year
LeadershipHere’s Why Investors Weren’t Excited About Biogen’s New CEO
By ReutersDecember 20, 2016
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
HealthMylan Will Start Selling Its Generic EpiPen at a Major Discount
By ReutersDecember 16, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
Health20 States Are Suing Mylan and Other Drug Companies for Allegedly Fixing Prices
By Reuters and Michelle TohDecember 16, 2016
Hepatitis C drug can cure, if patients can get it
HealthMerck Won a Mammoth $2.5 Billion from Gilead After Its Hepatitis C Drug Patent Suit
By ReutersDecember 15, 2016
Vitamin and Mineral pills
HealthWhy Did New Drug Approvals in the U.S. Plunge This Year?
By Sy MukherjeeDecember 15, 2016
Fortune Brainstorm Tech 2015
HealthKKR Just Sold This Drug Delivery Company for $5.5 Billion
By ReutersDecember 15, 2016
Sarepta Therapeutics New Global Headquarters
HealthInsurers are Rebelling Against the FDA’s Most Controversial 2016 Drug Approval
By Sy MukherjeeDecember 14, 2016
A logo is seen in front of the entrance at the headquarters of French drugmaker Sanofi in Paris
HealthA New Suitor Has Reportedly Replaced J&J in This Over $20 Billion Biotech Deal
By ReutersDecember 14, 2016
Man walks downstairs
HealthBig Pharma Just Had a Terrible, Horrible, No Good, Very Bad Week of Job Cuts
By Sy MukherjeeDecember 12, 2016
Interview with Andrew Left, Short Seller Behind Valeant Selloff on Enron Comparison
FinanceAfter Valeant, Short-Seller Citron Is Going After This Pharma Benefits Firm
By ReutersDecember 9, 2016
Fentanyl Citrate, a CLASS II Controlled Substance as classified by the Drug Enforcement Agency in the secure area of a local hospital Friday, July10, 2009. Joe Amon / The Denver Post
HealthFeds Arrest 6 Former Insys Execs for Allegedly Bribing Doctors
By Sy MukherjeeDecember 8, 2016
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
FinanceAbbott Labs Has Officially Moved to Kill Its Deal to Buy Alere
By ReutersDecember 8, 2016
483106863
HealthEverything You Need to Know About the Massive Health Reform Law That Just Passed Congress
By Sy MukherjeeDecember 7, 2016
President-Elect Donald Trump And Vice President Elect Pence Hold Election Victory Rally In Ohio
LeadershipDonald Trump Sent Biotech Stocks Plummeting with These 16 Words
By Sy MukherjeeDecember 7, 2016
1...
  • 61
  • 62
  • 63
  • 64
  • 65
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.